Alzira Leques
Obstetrics & Gynecology · Oxford, OHNPI 1265746655
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.9% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $692 and has fallen 96.8% since, to $22 in 2025.
Across 89 payments — averaging $22.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$428
- Aspira Women's Health Inc$226
- Exeltis, USA Inc.$182
- Channel Medsystems, Inc.$147
- Pfizer$133
- AMAG Pharmaceuticals, Inc.$101
- plus $765 from 22 others
What the payments were for
- Food & beverage$1,88195%
- Education$1015%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $428 |
| Aspira Women's Health Inc | 2 | $226 |
| Exeltis, USA Inc. | 11 | $182 |
| Channel Medsystems, Inc. | 2 | $147 |
| Pfizer | 7 | $133 |
| AMAG Pharmaceuticals, Inc. | 7 | $101 |
| Astellas Pharma US Inc | 5 | $98 |
| Bayer | 5 | $78 |
| Coopersurgical, Inc. | 4 | $74 |
| Gynesonics, Inc. | 3 | $71 |
| Therapeuticsmd, Inc. | 4 | $65 |
| Lupin Inc. | 4 | $60 |
| Mylan Pharmaceuticals Inc. | 3 | $50 |
| Sage Therapeutics, LLC | 2 | $36 |
| Hologic Sales And Service, LLC | 3 | $24 |
| Agile Therapeutics, Inc. | 1 | $22 |
| Evofem Biosciences, Inc. | 1 | $21 |
| Organon | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Mayne Pharma Commercial LLC | 1 | $18 |
| Novo Nordisk | 1 | $18 |
| Scynexis, Inc. | 1 | $17 |
| Amgen | 1 | $15 |
| Shield Therapeutics Inc | 1 | $15 |
| Baxter Healthcare | 1 | $15 |
| Avion Pharmaceuticals | 1 | $14 |
| Merck | 1 | $13 |
| Meditrina | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,983 in reported general payments places this provider in the 75th percentile of 1,376 obstetrics & gynecology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 12 | $1,341 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Oxford
- Samir AhujaMentor$430K
- Burton BrodskySylvania$202K
- Sandor MecsSteubenville$190K
- David SchwartzCincinnati$169K
- Erin OlahColumbus$97K
- David PortmanColumbus$94K
- Anita SomaniColumbus$93K
- Lorie Thomas-SchultzFindlay$92K
- Oluwatosin GojeCleveland$81K
- Gerard ReillyCincinnati$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.